Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study Group (Q71993108)
Jump to navigation
Jump to search
scientific article published on 01 September 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study Group |
scientific article published on 01 September 1995 |
Statements
Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study Group (English)
T Lenderink
M L Simoons
G A Van Es
F Van de Werf
M Verstraete
1 September 1995